PORT WASHINGTON, N.Y., Oct. 23, 2012 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Intermediates and Performance Chemicals, today announced that Albert Eilender, Chairman and CEO, is scheduled to present at the Singular Research 7th Annual Best of the Uncovereds Conference on Thursday, November 1, 2012 in Los Angeles, California.
Event: Singular Research 7th Annual Best of the Uncovereds
Date: November 1, 2012
Time: 1:30pm Pacific Time
Place: The Luxe Hotel, Los Angeles, California
A live webcast of this presentation will be provided at: http://www.singularresearch.com.
During the remainder of the day, ACETO management will meet with investors during a series of one-on-one meetings. Interested parties should contact Bill Jones at Singular (267-987-2082) to schedule a meeting.
ACETO Corporation, incorporated in 1947, is a global leader in the marketing, sales and distribution of products for Human Health (finished dosage form generics and nutraceutical products), Pharmaceutical Ingredients (pharmaceutical intermediates and active pharmaceutical ingredients) and Performance Chemicals (specialty chemicals and agricultural protection products). With business operations in nine countries, ACETO distributes over 1,100 chemical compounds used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. ACETO's global operations, including a staff of 26 in China and 12 in India are distinctive in the industry and enable its worldwide sourcing and regulatory capabilities.
The ACETO Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13058
CONTACT: Investor Relations Contact: Amy Glynn The Ruth Group (646) 536-7023 firstname.lastname@example.org